Patients Need to Shorten the Duration of a Cold vs Only Suppress the Symptoms

Published Online: Monday, March 21, 2011
The fifth in a five-part series looking at the pharmacist’s role in providing recommendations for cold and flu season talks about why pharmacists rank efficacy as the top consideration when providing counsel about OTC cold and flu products.

Click here to access this third-party resource.
Latest Articles
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.
Nasal corticosteroid sprays do not seem to be viable treatments for the common cold.
Latest Issues